Dario Pilla
Senior Research Assistant
With a background spanning molecular biology, high-throughput automation, and advanced AAV engineering, Dario brings nearly a decade of diverse industry experience to ExEd. His work focuses on optimising and characterising transgene cassettes for improved transient protein production and generating high-quality stably transformed cell pools.
Bio
Dario completed a BSc in Human Biosciences at the University of Plymouth, where his dissertation investigated the influence of glycolytic intermediates on LPS-induced inflammatory signalling. This early work shaped a lasting interest in how cellular pathways can be engineered and redirected for therapeutic impact.
Beginning his career at UK Biocentre, Dario spent two years supporting large-scale research programmes across academia, biotech and pharma. Working at the forefront of the UK’s COVID-19 diagnostic response, he helped develop high-throughput automated workflows that enabled national-level sample processing and rapid data turnaround during the pandemic.
Before joining ExEd, Dario spent five years in the gene therapy sector specialising in AAV capsid discovery and development. His work focused on generating novel capsids with improved gene delivery to the liver, heart and CNS, achieving more than four-fold increases in potency and enhanced immune evasion compared to proprietary benchmarks.
At ExEd, Dario plays a hands-on role in advancing the Genetic Syntax Engine, supporting partnership programmes and contributing to our innovative asset pipeline.
With a background spanning molecular biology, high-throughput automation, and advanced AAV engineering, Dario brings nearly a decade of diverse industry experience to ExEd. His work focuses on optimising and characterising transgene cassettes for improved transient protein production and generating high-quality stably transformed cell pools.
Bio
Dario completed a BSc in Human Biosciences at the University of Plymouth, where his dissertation investigated the influence of glycolytic intermediates on LPS-induced inflammatory signalling. This early work shaped a lasting interest in how cellular pathways can be engineered and redirected for therapeutic impact.
Beginning his career at UK Biocentre, Dario spent two years supporting large-scale research programmes across academia, biotech and pharma. Working at the forefront of the UK’s COVID-19 diagnostic response, he helped develop high-throughput automated workflows that enabled national-level sample processing and rapid data turnaround during the pandemic.
Before joining ExEd, Dario spent five years in the gene therapy sector specialising in AAV capsid discovery and development. His work focused on generating novel capsids with improved gene delivery to the liver, heart and CNS, achieving more than four-fold increases in potency and enhanced immune evasion compared to proprietary benchmarks.
At ExEd, Dario plays a hands-on role in advancing the Genetic Syntax Engine, supporting partnership programmes and contributing to our innovative asset pipeline.
With a background spanning molecular biology, high-throughput automation, and advanced AAV engineering, Dario brings nearly a decade of diverse industry experience to ExEd. His work focuses on optimising and characterising transgene cassettes for improved transient protein production and generating high-quality stably transformed cell pools.
Bio
Dario completed a BSc in Human Biosciences at the University of Plymouth, where his dissertation investigated the influence of glycolytic intermediates on LPS-induced inflammatory signalling. This early work shaped a lasting interest in how cellular pathways can be engineered and redirected for therapeutic impact.
Beginning his career at UK Biocentre, Dario spent two years supporting large-scale research programmes across academia, biotech and pharma. Working at the forefront of the UK’s COVID-19 diagnostic response, he helped develop high-throughput automated workflows that enabled national-level sample processing and rapid data turnaround during the pandemic.
Before joining ExEd, Dario spent five years in the gene therapy sector specialising in AAV capsid discovery and development. His work focused on generating novel capsids with improved gene delivery to the liver, heart and CNS, achieving more than four-fold increases in potency and enhanced immune evasion compared to proprietary benchmarks.
At ExEd, Dario plays a hands-on role in advancing the Genetic Syntax Engine, supporting partnership programmes and contributing to our innovative asset pipeline.
→